| pubmed-article:9846527 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:9846527 | lifeskim:mentions | umls-concept:C0301944 | lld:lifeskim |
| pubmed-article:9846527 | lifeskim:mentions | umls-concept:C0010592 | lld:lifeskim |
| pubmed-article:9846527 | lifeskim:mentions | umls-concept:C0072980 | lld:lifeskim |
| pubmed-article:9846527 | lifeskim:mentions | umls-concept:C0205195 | lld:lifeskim |
| pubmed-article:9846527 | lifeskim:mentions | umls-concept:C0332206 | lld:lifeskim |
| pubmed-article:9846527 | lifeskim:mentions | umls-concept:C0205355 | lld:lifeskim |
| pubmed-article:9846527 | pubmed:issue | 10 | lld:pubmed |
| pubmed-article:9846527 | pubmed:dateCreated | 1998-12-29 | lld:pubmed |
| pubmed-article:9846527 | pubmed:abstractText | Combined treatment of allograft recipients with anti-CD40 ligand and CTLA-4Ig (costimulation blockade) is a powerful promising albeit not consistently tolerizing therapy. It would be desirable to use an effective conventional immunosuppressive regimen in low doses or for a short course as an adjunct; however, cyclosporine treatment drastically blunts the ability of costimulation blockade to produce long-term engraftment. | lld:pubmed |
| pubmed-article:9846527 | pubmed:language | eng | lld:pubmed |
| pubmed-article:9846527 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9846527 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:9846527 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9846527 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9846527 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9846527 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9846527 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9846527 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9846527 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9846527 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9846527 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:9846527 | pubmed:month | Nov | lld:pubmed |
| pubmed-article:9846527 | pubmed:issn | 0041-1337 | lld:pubmed |
| pubmed-article:9846527 | pubmed:author | pubmed-author:LUMM | lld:pubmed |
| pubmed-article:9846527 | pubmed:author | pubmed-author:StromT BTB | lld:pubmed |
| pubmed-article:9846527 | pubmed:author | pubmed-author:LiX CXC | lld:pubmed |
| pubmed-article:9846527 | pubmed:author | pubmed-author:ZandM SMS | lld:pubmed |
| pubmed-article:9846527 | pubmed:author | pubmed-author:ZhengX XXX | lld:pubmed |
| pubmed-article:9846527 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:9846527 | pubmed:day | 27 | lld:pubmed |
| pubmed-article:9846527 | pubmed:volume | 66 | lld:pubmed |
| pubmed-article:9846527 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:9846527 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:9846527 | pubmed:pagination | 1387-8 | lld:pubmed |
| pubmed-article:9846527 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
| pubmed-article:9846527 | pubmed:meshHeading | pubmed-meshheading:9846527-... | lld:pubmed |
| pubmed-article:9846527 | pubmed:meshHeading | pubmed-meshheading:9846527-... | lld:pubmed |
| pubmed-article:9846527 | pubmed:meshHeading | pubmed-meshheading:9846527-... | lld:pubmed |
| pubmed-article:9846527 | pubmed:meshHeading | pubmed-meshheading:9846527-... | lld:pubmed |
| pubmed-article:9846527 | pubmed:meshHeading | pubmed-meshheading:9846527-... | lld:pubmed |
| pubmed-article:9846527 | pubmed:meshHeading | pubmed-meshheading:9846527-... | lld:pubmed |
| pubmed-article:9846527 | pubmed:meshHeading | pubmed-meshheading:9846527-... | lld:pubmed |
| pubmed-article:9846527 | pubmed:meshHeading | pubmed-meshheading:9846527-... | lld:pubmed |
| pubmed-article:9846527 | pubmed:meshHeading | pubmed-meshheading:9846527-... | lld:pubmed |
| pubmed-article:9846527 | pubmed:meshHeading | pubmed-meshheading:9846527-... | lld:pubmed |
| pubmed-article:9846527 | pubmed:meshHeading | pubmed-meshheading:9846527-... | lld:pubmed |
| pubmed-article:9846527 | pubmed:meshHeading | pubmed-meshheading:9846527-... | lld:pubmed |
| pubmed-article:9846527 | pubmed:meshHeading | pubmed-meshheading:9846527-... | lld:pubmed |
| pubmed-article:9846527 | pubmed:meshHeading | pubmed-meshheading:9846527-... | lld:pubmed |
| pubmed-article:9846527 | pubmed:meshHeading | pubmed-meshheading:9846527-... | lld:pubmed |
| pubmed-article:9846527 | pubmed:year | 1998 | lld:pubmed |
| pubmed-article:9846527 | pubmed:articleTitle | Combined costimulation blockade plus rapamycin but not cyclosporine produces permanent engraftment. | lld:pubmed |
| pubmed-article:9846527 | pubmed:affiliation | Department of Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, Massachusetts 02215, USA. | lld:pubmed |
| pubmed-article:9846527 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:9846527 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:9846527 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9846527 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9846527 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9846527 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9846527 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9846527 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9846527 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9846527 | lld:pubmed |
